英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
jestingstock查看　jestingstock　在百度字典中的解释百度英翻中〔查看〕
jestingstock查看　jestingstock　在Google字典中的解释Google英翻中〔查看〕
jestingstock查看　jestingstock　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Ferriprox (deferiprone): Information for patients
    Your healthcare provider may temporarily stop treatment with Ferriprox tablets if you develop increased liver enzyme levels and they continue to be increased Ferriprox can cause decreased levels of zinc in your blood
  • label - accessdata. fda. gov
    FERRIPROX Oral Solution is indicated for the treatment of transfusional iron overload in adult and pediatric patients 3 years of age and older with thalassemia syndromes, sickle cell disease or
  • Ferriprox (deferiprone): Information for healthcare professionals
    Ferriprox (deferiprone) is an iron chelator with expanded FDA approval for the treatment of transfusional iron overload due to sickle cell disease, thalassemia syndromes or other anemias in adult and pediatric patients 3 years of age and older
  • How I treat myelofibrosis - American Society of Hematology
    At present, there is no curative treatment other than allogeneic hemopoietic stem cell transplantation (allo-SCT), which can be applied to a minority of patients Therefore, treatment remains essentially palliative and aimed at controlling disease symptoms and complications and improving the patients’ quality of life
  • Pacritinib Versus Best Available Therapy to Treat Patients With . . .
    Study Overview Brief Summary Phase 3, randomized, controlled study to evaluate the safety and efficacy of oral pacritinib compared to Best Available Therapy (BAT) in patients with thrombocytopenia and primary or secondary myelofibrosis
  • label - accessdata. fda. gov
    FERRIPROX Tablets are indicated for the treatment of transfusional iron overload in adult and pediatric patients 8 years of age and older with thalassemia syndromes, sickle cell disease or
  • Elritercept and Ruxolitinib in Myelofibrosis - Clinical Trials Registry . . .
    A Phase 2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KER-050 as Monotherapy or in Combination With Ruxolitinib in Participants With Myelofibrosis
  • Pacritinib vs Best Available Therapy in Patients With Myelofibrosis
    This phase 3 randomized clinical trial compares the efficacy and safety of Janus kinase 2 inhibitor pacritinib with that of best available therapy, including ruxolitinib, in patients with myelofibrosis and thrombocytopenia





中文字典-英文字典  2005-2009